New Research Reveals the First Atomic-Level Visualization of Friction – AZoM

Jul 26 2022Reviewed by Alex Smith

Friction is an unavoidable opponent for devices with mechanical parts. It is a primary cause of service failure and may shorten the lifetime of any equipment, from bicycles to cars to aircraft and manufacturing lines.

Image Credit: Shutterstock.com/ ETAP

A new study led by the University of Pittsburgh reveals the atomic-scale friction of a single tungsten asperity, or rougher edge, in real-time, using electron microscopy for the first time to demonstrate atomic motion. The research, conducted by two Swanson School of Engineering groups, was just published in the journal Nature Nanotechnology.

Until now, no one has been able to actually see the atomically resolved friction process with a clear-cut interface, so the relationship between the friction mechanisms and the interface hasnt been fully understood. In this study, we were able to actually see the sliding pathway of interface atoms and the dynamic strain and stress evolution on the interface that has only previously been shown by simulations.

Guofeng Wang, CNG Faculty Fellow and Professor, Mechanical Engineering and Materials Science, University of Pittsburgh

Wangs group worked with the now-retired John Swanson. Endowed Professor Scott X. Maos Swanson School research group will produce the first atomic-scale picture of friction. Maos group was able to see the movement of atoms across the surface when two surfaces interacted and moved using a high-resolution transmission electron microscope.

Wangs team was subsequently able to utilize computer simulations to confirm what the tiny visualizations revealed and learn more about the forces at work.

Though this research focused on tungsten atoms because of their exceptional resistance to the heat generated by the microscope, the approach may be used on any material to better understand friction and wear.

What we found is that no matter how smooth and clean the surface is, friction still occurs at the atomic level. Its completely unavoidable. However, this knowledge can lead to better lubricants and materials to minimize friction and wear as much as possible, extending the life of mechanical systems.

Guofeng Wang, CNG Faculty Fellow and Professor, Mechanical Engineering and Materials Science, University of Pittsburgh

Xiang Wang, a recently graduated Ph.D. student, and Zhenyu Liu, a post-doctoral researcher, led the study. Yang He, Susheng Tan, Guofeng Wang, and Scott X. Mao collaborated on it. The National Science Foundation provided funding for this research (NSF CMMI 1824816).

Wang, X., et al. (2022) Atomic-scale friction between single-asperity contacts unveiled through in situ transmission electron microscopy. Nature Nanotechnology. doi.org/10.1038/s41565-022-01126-z.

Source: https://www.pitt.edu/

See the original post:
New Research Reveals the First Atomic-Level Visualization of Friction - AZoM

Nanotechnology Market Scope and Regional Outlook, 2022 Analysis & Forecast To 2030 By Key Players, Share, Trend, Segmentation This Is Ardee -…

UNITED STATES Key Companies Covered in the Nanotechnology MarketResearch are3M Company, Ablynx N.V., Advanced Nano Products Co., Ltd., Altair Nanotechnologies Inc., Ansell Limited, Biosensors International Group, Ltd., Bruker Corporation, eSpin Technologies, Inc., Fujitsu Laboratories Ltd., Honeywell International Inc., Imina Technologies SA, Kleindiek Nanotechnik GmbH, Lockheed Martin Corporation, Nano Magic LLC, Nanonics Imaging Ltd., Thermo Fisher Scientific Inc.,and other key market players.

Nanotechnology is the manipulation of matter on a near-atomic scale to produce new structures, materials and devices.

Download Free Sample of This Strategic Report :-https://www.quadintel.com/request-sample/nanotechnology-market-1/QI043

Our report Company predicts that the global nanotechnology market is estimated to touch a valuation of USD 16,261 million, registering a CAGR of 23.4% during the forecast period (2022-2028).

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into globalnanotechnology market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the nanotechnology industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, and region. The global market for nanotechnology can be segmented by type: nano sensors, nanodevices, nanomaterials, others. According to the research, the nanomaterials segment had the largest share in the global nanotechnology market.

Nanotechnology market is further segmented by application: aerospace & defense, chemicals, electrical & electronics, energy, healthcare, industrial, others. In 2021, the healthcare segment made up the largest share of revenue generated by the nanotechnology market. Based on region, the nanotechnology market is segmented into: North America, Asia Pacific, Europe, Rest of the World (ROW).

Download Sample Report, SPECIAL OFFER (Avail an Up-to 30% discount on this report ): https://www.quadintel.com/request-sample/nanotechnology-market-1/QI043

By type:

nano sensorsnanodevicesnanomaterialsothers

By application:aerospace & defensechemicalselectrical & electronicsenergyhealthcareindustrialothers

By region:North AmericaAsia PacificEuropeRest of the World (ROW)

Request Full Report, here : https://www.quadintel.com/request-sample/nanotechnology-market-1/QI043

Key Questions Answered in the Market Report

? How did the COVID-19 pandemic impact the adoption of by various pharmaceutical and life sciences companies?? What is the outlook for the impact market during the forecast period 2021-2030?? What are the key trends influencing the impact market? How will they influence the market in short-, mid-, and long-term duration?? What is the end user perception toward?? How is the patent landscape for pharmaceutical quality? Which country/cluster witnessed the highest patent filing from January 2014-June 2021?? What are the key factors impacting the impact market? What will be their impact in short-, mid-, and long-term duration?? What are the key opportunities areas in the impact market? What is their potential in short-, mid-, and long-term duration?? What are the key strategies adopted by companies in the impact market?? What are the key application areas of the impact market? Which application is expected to hold the highest growth potential during the forecast period 2021-2030?? What is the preferred deployment model for the impact? What is the growth potential of various deployment models present in the market?? Who are the key end users of pharmaceutical quality? What is their respective share in the impact market?? Which regional market is expected to hold the highest growth potential in the impact market during the forecast period 2021-2030?? Which are the key players in the impact market?

About Quadintel:

We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Quadintel is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Quadintel:Email:sales@quadintel.comAddress: Office 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATESTel: +1 888 212 3539 (US TOLL FREE)Website:https://www.quadintel.com/

Continue reading here:
Nanotechnology Market Scope and Regional Outlook, 2022 Analysis & Forecast To 2030 By Key Players, Share, Trend, Segmentation This Is Ardee -...

How do nanoparticles grow? Atomic-scale movie upends 100-year-old theory – Nanowerk

Jul 26, 2022(Nanowerk News) For decades, a textbook process known as Ostwald ripening, named for the Nobel Prize-winning chemist Wilhelm Ostwald, has guided the design of new materials including nanoparticles tiny materials so small they are invisible to the naked eye.According to this theory, small particles dissolve and redeposit onto the surface of large particles, and the large particles continue to grow until all of the small particles have dissolved.But now, new video footage captured by Berkeley Lab scientists reveals that nanoparticle growth is directed not by difference in size, but by defects.The scientists recently reported their findings in the journal Nature Communications ("Defect-mediated ripening of core-shell nanostructures").New video footage captured by Berkeley Lab scientists reveals for the first time that nanoparticle growth is directed not by difference in size, but by defects. (Image: Haimei Zheng, Berkeley Lab)This is a huge milestone. We are rewriting textbook chemistry, and its very exciting, said senior author Haimei Zheng, a senior scientist in Berkeley Labs Materials Sciences Division and an adjunct professor of materials science and engineering at UC Berkeley.For the study, the researchers suspended a solution of cadmium sulfide (CdS) nanoparticles with cadmium chloride (CdCl2) and hydrogen chloride (HCl) in a custom liquid sample holder. The researchers exposed the solution with an electron beam to produce Cd-CdCl2 core-shell nanoparticles (CSNPs) which look like flat, hexagonal discs where cadmium atoms form the core, and cadmium chloride forms the shell.Using a technique called high-resolution liquid cell transmission electron microscopy (LC-TEM) at the Molecular Foundry, the researchers captured real-time, atomic-scale LC-TEM videos of Cd-CdCl2 CSNPs ripening in solution.In one key experiment, an LC-TEM video shows a small Cd-CdCl2 core-shell nanoparticle merging with a large Cd-CdCl2 CSNP to form a larger Cd-CdCl2 CSNP. However, the direction of growth was guided not by a difference in size but by a crack defect in the shell of the initially larger CSNP. The finding was very unexpected, but were very happy with the results, said Qiubo Zhang, first author and postdoctoral researcher in the Materials Sciences Division.The researchers say that their work is the highest resolution LC-TEM video ever recorded. The advance monitoring how nanoparticles ripen in solution in real time was enabled by a custom-made, ultrathin liquid cell that secures a tiny amount of liquid between two carbon-film membranes on a copper grid. The researchers observed the liquid sample through ThemIS, a specialized electron microscope at the Molecular Foundry that is capable of recording atomic-scale changes in liquids at a speed of 40-400 frames per second. The microscopes high-vacuum environment keeps the liquid sample intact.Our study fills in the gap for nanomaterial transformations that cant be predicted by traditional theory. Zheng said, who pioneered LC-TEM at Berkeley Lab in 2009 and is a leading expert in the field. I hope our work inspires others to think of new rules to design functional nanomaterials for new applications.

Continued here:
How do nanoparticles grow? Atomic-scale movie upends 100-year-old theory - Nanowerk

Nanoparticle catalyst destroys ‘forever chemicals’ with sunlight – Nanowerk

Jul 25, 2022(Nanowerk News) Rice University chemical engineers have improved their design for a light-powered catalyst that rapidly breaks down PFOA, one of the worlds most problematic forever chemical pollutants.llustration showing how a composite material containing sheets of boron nitride (lattice of blue and silver balls) and nanoparticles of titanium dioxide (gray spheres) uses long-wave ultraviolet energy in sunlight to photocatalyse the breakdown of PFOA into carbon dioxide, fluorine and minerals. (Image: M.S. Wong, Rice University)Michael Wong and his students made the surprising discovery in 2020 that boron nitride, a commercially available powder thats commonly used in cosmetics, could destroy 99% of PFOA, or perfluorooctanoic acid, in water samples within just a few hours when it was exposed to ultraviolet light with a wavelength of 254 nanometers.That was great because PFOA is an increasingly problematic pollutant thats really hard to destroy, said Wong, corresponding author of a study about the redesigned catalyst in Chemical Engineering Journal ("Titanium oxide improves boron nitride photocatalytic degradation of perfluorooctanoic acid"). But it was also less than ideal because the boron nitride was activated by short-wave UV, and the atmosphere filters out almost all of the short-wave UV from sunlight. We wanted to push as much as possible boron nitrides ability to access energy from other wavelengths of sunlight.Long-wave UV, or UV-A, has wavelengths ranging from about 315-400 nanometers. Its what causes suntans and sunburns, and its plentiful in sunlight that reaches Earth. Boron nitride is a semiconductor, and it isnt activated by UV-A. Titanium dioxide, a common ingredient in sunscreen, is a semiconductor that is activated by UV-A, and it had even been shown to catalyze the breakdown of PFOA, albeit very slowly, when exposed to UV-A.So Wong and study co-lead authors Bo Wang, Lijie Duan and Kimberly Heck decided to create a composite of boron nitride and titanium dioxide that married the best features of the individual catalysts. In their new study, they showed the UV-A powered composites destroyed PFOA about 15 times faster than plain titanium dioxide photocatalysts.By analyzing photocurrent response measurements and other data, Wongs team learned how its semiconductor composite harvested UV-A energy to break apart PFOA molecules in water. In outdoor experiments using plastic water bottles under natural sunlight, they found the boron nitride-titanium dioxide composites could degrade about 99% of PFOA in deionized water in less than three hours. In salty water, that process took about nine hours.Mounting evidence suggests PFOA is harmful to human health. Some U.S. states have set limits on PFOA contamination in drinking water, and in March 2021 the Environmental Protection Agency announced plans to develop federal standards.Growing regulatory pressure to set PFOA standards has water treatment plants looking for new and cost-efficient ways of removing PFOA from water, Wong said.PFOA is one of the most prevalent PFAS (perfluoroalkyl and polyfluoroalkyl substances), a family of compounds developed in the 20th century to make coatings for waterproof clothing, food packaging and other products. PFAS have been dubbed forever chemicals because they arent easily degraded and tend to linger in the environment. Wong said his team is assessing how well its composite photocatalyst works for breaking down other PFAS.He said the boron nitride and composite catalyst technologies have already attracted attention from several industrial partners in the Rice-based Nanosystems Engineering Research Center for Nanotechnology-Enabled Water Treatment (NEWT), which is funded by the National Science Foundation to develop off-grid water treatment systems.

More:
Nanoparticle catalyst destroys 'forever chemicals' with sunlight - Nanowerk

Global Diamond Turning Lathe Market 2022 to 2028 Competitive Analysis: Edmund Optics, Moore Nanotechnology Systems, Nanophorm, Innolite This Is Ardee…

Global Diamond Turning Lathe Market from 2022 to 2028 is the title of a professional market research study MarketandResearch.biz that examines market growth prospects and possibilities. This research analysis aims to give background information on the worldwide Diamond Turning Lathe markets competition, current market trends, market potential, growth rate, and other vital statistics.

The study has thoroughly researched critical variables such as drivers and constraints, opportunities, production, market players, and competition in the worldwide Diamond Turning Lathe market from 2022 to 2028. This research forecasts the evolution of the market in terms of revenue throughout the forecast period. The study would offer new entrants information on revenue estimates for the worldwide Diamond Turning Lathe market and its sub-segments.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketandresearch.biz/sample-request/245891

The study describes detailed consumption statistics, international and regional market imports and exports, income, gross margin analysis, etc. The leading market players then used acquisitions and expansions to ensure their growth in the worldwide Diamond Turning Lathe market, included in the research. The Five Forces model by Porter and SWOT analysis also includes an in-depth examination of the worldwide Diamond Turning Lathe market and the most recent market trends, growth opportunities, regional analysis, strategic recommendations, and emerging segments.

The following product type are highlighted in the analysis:

The following are the significant applications highlighted in the research:

The following manufacturers are included prominently in the market report:

This study focuses on several essential regions regionally:

ACCESS FULL REPORT: https://www.marketandresearch.biz/report/245891/global-diamond-turning-lathe-market-2022-by-manufacturers-regions-type-and-application-forecast-to-2028

The Reports Important Answers to the Following Questions:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on 1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: 1-201-465-4211Email: sales@marketandresearch.biz

Read the original:
Global Diamond Turning Lathe Market 2022 to 2028 Competitive Analysis: Edmund Optics, Moore Nanotechnology Systems, Nanophorm, Innolite This Is Ardee...

The hetero-interface is the device: a computational approach – Nanowerk

Jul 26, 2022(Nanowerk News) Assembling Lego-like 2D heterostructures can give rise to emergent properties and functionalities very different from the intrinsic characteristics of the constituents.Density functional theory (DFT)-based band-structure calculations can shed light on interfacial properties of different heterostructures.The interface of 2D perovskites with TMDs can lead to new properties broadband light absorption and emission, and enhanced charge separation across the interface that could be utilised in future optoelectronics. (Image: FLEET)Interface properties of 2D perovskite/TMD heterostructuresHeterostructures based on different 2D materials have resulted in new properties that can be significantly different from those of the individual materials. Such heterostructures can be made by assembling different kinds of atomically-thin 2D materials.One such family of 2D materials, the 2D perovskites, show interesting photophysical properties and better stability compared to the typical bulk perovskites. However, till now, near-infrared (NIR)/visible-range optoelectronic device performance metrics of 2D perovskites have been quite poor owing to certain intrinsic and materials-specific limitations such as large bandgaps, unusually high exciton binding energies and low optical absorption.A new study led by researchers from Monash University looks at a methodology to improve the optoelectronic device performance and extend the functionalities of 2D perovskites by conjugating them with optically active transition metal dichalcogenides (TMDs). 2D perovskites and TMDs are structurally dissimilar, however, they can form clean interfaces owing to van der Waals interactions between the stacked layers. Using accurate first principles calculations, the authors demonstrate that the novel interface (band alignment) and transport properties are feasible in 2D perovskite/TMD heterostructures which can be widely tuned based on appropriate choice of the constituents.To understand the interface properties accurately, the authors created lattice matched structures of the interfaces and explored their properties through highly memory intensive computations using supercomputing facilities.In specific systems, the predicted type-II alignments with NIR/visible bandgaps can enable enhanced optical absorption at comparatively lower energies. Also, sizeable band offsets and possibility of interlayer excitons with lower dissociation energies can lead to easier interlayer separation of the excited charge carriers across two materials. These render the possibility of achieving higher photocurrents and improved solar cell efficiencies.The researchers also predict the possibility of type-I systems for recombination-based devices like light-emitting diodes and type-III systems for achieving tunnelling transport. Additionally, they also show significant strain tolerance in such 2D perovskite/TMD heterostructures, a pre-requisite for flexible sensors.Overall, these findings demonstrate that a computationally-guided selection of heterostructures could offer better platforms than intrinsic materials for specific device applications and have potential in next-generation multifunctional devices such as flexible photosensors or LEDs, says FLEET CI A/Prof Nikhil Medhekar who led the work with PhD student Abin Varghese and postdoctoral researcher Dr. Yuefeng Yin.The charge transport mechanism across the WSe2/SnSe2 heterostructure can be controlled either using light or by applying an out-of-plane electric field, which can lead to positive or negative photo responsivity (R). (Image: FLEET)Tuning polarity of photogenerated currentsExploring the physics of 2D heterostructures further, the team collaborated with experimentalists led by Prof. Saurabh Lodha from IIT Bombay, India to explain the emergence of a yet undiscovered optoelectronic phenomena. In the first work on WSe2/SnSe2 heterostructures, upon illumination, the polarity of the photocurrent showed a dependence on the type of electrical transport (thermionic or tunnelling) across the interface of the heterostructure.The researchers at Monash employed density functional theory based electric field dependent band-structure calculations and attributed this observation to the nature of band alignment at the interface. Together, they showed that a change in band alignment from type-II to type-III resulted in a change in polarity of photocurrent from positive to negative.In terms of the performance of photodetectors, the responsivity and response time are crucial metrics. In this study a high negative responsivity and fast response time was experimentally observed in the device prototypes which are encouraging for further development of 2D materials-based devices for practical applications.In another heterostructure comprising black phosphorous and MoS2, the experiments illustrated an illumination wavelength-dependence on the polarity of photoconduction. The negative photoconductance seen at specific wavelengths above the absorption edge of MoS2 could be controllably and reversibly tuned to positive photoconductance at lower wavelengths. The threshold wavelength for crossover between negative and positive photoconductance had a crucial dependence on the flake thicknesses. Thickness-dependent band-structure calculations carried by researchers from Monash clearly showed the possibility of an increase in recombination of charge carriers for specific thicknesses which could lead to negative photoconductance, thus aiding the conclusions.These studies demonstrate new methods to control the sensing mechanism in photodetectors which has not yet been studied in such details.The studiesNearInfrared and VisibleRange Optoelectronics in 2D Hybrid Perovskite/Transition Metal Dichalcogenide Heterostructures published in Advanced Materials Interfaces.Polarity-Tunable Photocurrent through Band Alignment Engineering in a High-Speed WSe2/SnSe2 Diode with Large Negative Responsivity published in ACS Nano.Wavelength-Controlled Photocurrent Polarity Switching in BP-MoS Heterostructure published in Advanced Functional Materials.

Read more from the original source:
The hetero-interface is the device: a computational approach - Nanowerk

Neuromorphic computing with optically driven nonlinear fluid dynamics – Nanowerk

Jul 25, 2022(Nanowerk News) Sunlight sparkling on water evokes the rich phenomena of liquidlight interaction, spanning spatial and temporal scales. While the dynamics of liquids have fascinated researchers for decades, the rise of neuromorphic computing has sparked significant efforts to develop new, unconventional computational schemes based on recurrent neural networks, crucial to supporting wide range of modern technological applications, such as pattern recognition and autonomous driving.As biological neurons also rely on a liquid environment, a convergence may be attained by bringing nanoscale nonlinear fluid dynamics to neuromorphic computing.Researchers from University of California San Diego recently proposed a novel paradigm where liquids, which usually do not strongly interact with light on a micro- or nanoscale, support significant nonlinear response to optical fields.As reported in Advanced Photonics ("Thin liquid film as an optical nonlinear-nonlocal medium and memory element in integrated optofluidic reservoir computer"), the researchers predict a substantial lightliquid interaction effect through a proposed nanoscale gold patch operating as an optical heater and generating thickness changes in a liquid film covering the waveguide.Simulation result of light affecting liquid geometry, which in turn affects reflection and transmission properties of the optical mode, thus constituting a two-way lightliquid interaction mechanism. The degree of deformation serves as an optical memory allowing to store the power magnitude of the previous optical pulse and use fluid dynamics to affect the subsequent optical pulse at the same actuation region, thus constituting an architecture where memory is part of the computation process. (Image: Gao et al.)The liquid film functions as an optical memory. Heres how it works: Light in the waveguide affects the geometry of the liquid surface, while changes in the shape of the liquid surface affect the properties of the optical mode in the waveguide, thus constituting a mutual coupling between the optical mode and the liquid film. Importantly, as the liquid geometry changes, the properties of the optical mode undergo a nonlinear response; after the optical pulse stops, the magnitude of liquid films deformation indicates the power of the previous optical pulse.Remarkably, unlike traditional computational approaches, the nonlinear response and the memory reside at the same spatial region, thus suggesting realization of a compact (beyond von-Neumann) architecture where memory and computational unit occupy the same space. The researchers demonstrate that the combination of memory and nonlinearity allow the possibility of reservoir computing capable of performing digital and analog tasks, such as nonlinear logic gates and handwritten image recognition.Their model also exploits another significant liquid feature: nonlocality. This enables them to predict computation enhancement that is simply not possible in solid state material platforms with limited nonlocal spatial scale. Despite nonlocality, the model does not quite achieve the levels of modern solid-state optics-based reservoir computing systems, yet the work nonetheless presents a clear roadmap for future experimental works aiming to validate the predicted effects and explore intricate coupling mechanisms of various physical processes in a liquid environment for computation.Using multiphysics simulations to investigate coupling between light, fluid dynamics, heat transport, and surface tension effects, the researchers predict a family of novel nonlinear and nonlocal optical effects. They go a step further by indicating how these can be used to realize versatile, nonconventional computational platforms. Taking advantage of a mature silicon photonics platform, they suggest improvements to state-of-the-art liquid-assisted computation platforms by around five orders magnitude in space and at least two orders of magnitude in speed.

See the original post here:
Neuromorphic computing with optically driven nonlinear fluid dynamics - Nanowerk

Global Biosensors Market Report 2022-2035: $1.2 Billion Invested in the Last 5 Years with Further Growth Expected – GlobeNewswire

Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Biosensors Market: Focus on Drug Discovery and Development - Distribution by Type of Biosensor, Type of End User and Key Geographies - Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.

At present, various types of biosensors, including optical biosensors, electrochemical biosensors, thermal biosensors and others, are being deployed across different steps of drug discovery, such as disease modelling, target identification/validation, lead identification, lead optimization and other applications.

The use of biosensing technologies in drug discovery operations is expected to improve the overall R&D productivity by enabling accurate screening and identification of lead drug compounds. Currently, more than 80 biosensors are available in the market / being developed by various industry stakeholders for drug discovery and development purposes.

Further, over USD 1.2 billion has been invested in this market by both private and public sector investors, in the last five years. Interestingly, close to 50% of the aforementioned amount was invested in the last two years, reflecting the increasing interest of stakeholders in this domain.

It is also worth highlighting that over 370 patents related to biosensors in drug discovery have been filed/granted, highlighting the continuous pace of innovation in this field. Considering the active initiatives being undertaken by players in this domain, we are led to believe that the opportunity for stakeholders in this niche, but upcoming, industry is likely to grow at a commendable pace in the foreseen future.

Scope of the Report

The"Biosensors Market: Focus on Drug Discovery and Development - Distribution by Type of Biosensor (Optical, Electrochemical, Thermal and Others), Type of End User (Academic and Research Institutes and Industry Players) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) - Industry Trends and Global Forecasts, 2022-2035"report features an extensive study of the current market landscape and future potential of biosensors in drug discovery, over the next 13 years. The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

5. PRODUCT COMPETITIVENESS ANALYSIS

6. COMPANY PROFILES: BIOSENSORS DEVELOPERS FOR DRUG DISCOVERY APPLICATIONS

7. BRAND POSITIONING ANALYSIS

8. FUNDING AND INVESTMENT ANALYSIS

9. PUBLICATION ANALYSIS

10. GLOBAL EVENT ANALYSIS

11. PATENT ANALYSIS

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/qzyzgy

Read more from the original source:
Global Biosensors Market Report 2022-2035: $1.2 Billion Invested in the Last 5 Years with Further Growth Expected - GlobeNewswire

Nanobots and robotic technology to improve the success rate of IVF – Business Standard

Ghaziabad (Uttar Pradesh) [India], July 25 (ANI/GPRC): With recent technical advancements made in the field of fertility treatment, the procedures of Artificial Reproductive Techniques (ART) have made humungous improvements in terms of success rates and safety. Intracytoplasmic Sperm Injection (ICSI) is a form of the micro-assisted fertilisation process, one of the common IVF procedures performed clinically for over 20 years.

While the IVF procedure involves mixing thousands of motile sperms with each egg in a dish known as insemination of eggs, expecting that the sperms and eggs would interact through biochemistry. But in cases where either egg or sperm factors are deficient, then very few eggs become fertilised after incubation. However, ICSI has proven to be of immense advantages in cases of Oligozoospermia (low sperm count), Teratozoospermia (abnormal morphology of sperms) and Sperm Transport Disorder, where sperms are produced in adequate numbers, but with depleted motility, quality and concentration.

"ICSI has revolutionized in the treatment of male infertility and when combined with IVF procedure, sperm requirement for egg fertilization has dropped from hundred to only one viable sperm. This has led to the recent development of aggressive new techniques to provide viable sperm for egg fertilization from men with low or no sperm count. Making use of Artificial intelligence, nanotechnology, Laser Assisted Hatching and robotic ICSI procedures have revolutionised the outcomes through selection of the best sperms and best embryos." said Dr Gunjan Gupta Govil, Founder and Chairman, Gunjan IVF World Group

As of now, the Artificial Intelligence-based technology, which is still under clinical trial has a very high predictive success in identifying the best embryo, in terms of its growth pattern. In this technique, the AI system reviews a massive amount of data (over hundreds of images of each embryo) analyses the greatest likelihood of each embryo to develop into a fetal heart. The embryo with the highest score, and therefore the highest potential for leading to a viable foetus, can then be selected for transfer.

"With the inception of automation in ICSI through robotic and nanotechnology, has provided a viable novel technique to analyse oocyte penetration in real time via selection of the best sperm or embryo. In nanotechnology, a nanobot is released for selecting and transporting the best sperm cell until it penetrates into the egg, before implanting the healthy embryo in the uterus. Whereas in robot-assisted ICSI, the system performs visual tracking of the single sperm, robotic immobilization of sperm, aspiration of sperm with picoliter volume, and insertion of sperm into an oocyte with a high degree of reproducibility. Requiring minimal human involvement, various such trials have been successfully conducted with a high success rate of above 90 per cent and survival rate of 90.7 per cent." added Dr Gunjan.

In some cases, the possibilities also arise that the embryo implantation to the uterus is not successful, pertaining to sporadic reasons. In such cases, once the best embryo is chosen, a procedure known as laser-assisted hatching is performed on the selected embryo before implantation. Since in some situations, the outer layer of the embryo may thicken abnormally, laser-assisted hatching scientifically allows to make a small opening on the outer layer making it easier for the embryo to implant better to the endometrium.

Having provided the best in class technology for years, it is the vision and endeavour of Gunjan IVF World to provide Affordable, Reliable and Transparent treatment to couples battling fertility issues and bring Khushiyon Ki Goonj in their lives.

This story is provided by GPRC. ANI will not be responsible in any way for the content of this article. (ANI/GPRC)

DISCLAIMER

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance. We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

See the original post:
Nanobots and robotic technology to improve the success rate of IVF - Business Standard

The ABCs of AI, algorithms and machine learning – Marketplace

Advanced computer programs influence, and can even dictate, meaningful parts of our lives. Think of streaming services, credit scores, facial recognition software.

As this technology becomes more sophisticated and more pervasive, its important to understand the basic terminology.

People often use algorithm, machine learning and artificial intelligence interchangeably. There is some overlap, but theyre not the same things.

We decided to call up a few experts to help us get a firm grasp on these concepts, starting with a basic definition of algorithm. The following is an edited transcript of the episode.

Melanie Mitchell, Davis professor of complexity at the Santa Fe Institute, offered a simple explanation of a computer algorithm.

An algorithm is a set of steps for solving a problem or accomplishing a goal, she said.

The next step up is machine learning, which uses algorithms.

Rather than a person programming in the rules, the system itself has learned, Mitchell said.

For example, speech recognition software, which uses data to learn which sounds combine to become words and sentences. And this kind of machine learning is a key component of artificial intelligence.

Artificial intelligence is basically capabilities of computers to mimic human cognitive functions, said Anjana Susarla, who teaches responsible AI at Michigan State Universitys Broad College of Business.

She said we should think of AI as an umbrella term.

AI is much more broader, all-encompassing, compared to only machine learning or algorithms, Susarla said.

Thats why you might hear AI as a loose description for a range of things that show some level of intelligence. Like software that examines the photos on your phone to sort out the ones with cats to advanced spelunking robots that explore caves.

Heres another way to think of the differences among these tools: cooking.

Bethany Edmunds, professor and director of computing programs at Northeastern University, compares it to cooking.

She says an algorithm is basically a recipe step-by-step instructions on how to prepare something to solve the problem of being hungry.

If you took the machine learning approach, you would show a computer the ingredients you have and what you want for the end result. Lets say, a cake.

So maybe it would take every combination of every type of food and put them all together to try and replicate the cake that was provided for it, she said.

AI would turn the whole problem of being hungry over to the computer program, determining or even buying ingredients, choosing a recipe or creating a new one. Just like a human would.

So why do these distinctions matter? Well, for one thing, these tools sometimes produce results with biased outcomes.

Its really important to be able to articulate what those concerns are, Edmunds said. So that you can really dissect where the problem is and how we go about solving it.

Because algorithms, machine learning and AI are pretty much baked into our lives at this point.

Columbia Universitys engineering school has a further explanation of artificial intelligence and machine learning, and it lists other tools besides machine learning that can be part of AI. Like deep learning, neural networks, computer vision and natural language processing.

Over at the Massachusetts Institute of Technology, they point out that machine learning and AI are often used interchangeably because these days, most AI includes some amount of machine learning. A piece from MITs Sloan School of Management also gets into the different subcategories of machine learning. Supervised, unsupervised and reinforcement, like trial and error with kind of digital rewards. For example, teaching an autonomous vehicle to drive by letting the system know when it made the right decision like not hitting a pedestrian, for instance.

That piece also points to a 2020 survey from Deloitte, which found that 67% of companies are already using machine learning, and 97% were planning to in the future.

IBM has a helpful graphic to explain the relationship among AI, machine learning, neural networks and deep learning, presenting them as Russian nesting dolls with the broad category of AI as the biggest one.

And finally, with so many businesses using these tools, the Federal Trade Commission has a blog laying out some of the consumer risks associated with AI and the agencys expectations of how companies should deploy it.

Excerpt from:
The ABCs of AI, algorithms and machine learning - Marketplace

Global Machine Learning Market is Expected to Grow at a CAGR of 39.2 % by 2028 – Digital Journal

According to the latest research by SkyQuest Technology, the Global Machine Learning Market was valued at US$ 16.2 billion in 2021, and it is expected to reach a market size of US$ 164.05 billion by 2028, at a CAGR of 39.2 % over the forecast period 20222028. The research provides up-to-date Machine Learning Market analysis of the current market landscape, latest trends, drivers, and overall market environment.

Software systems may forecast events more correctly with the use of machine learning (ML), a type of artificial intelligence (AI), without needing to be explicitly told to do so. Machine learning algorithms use historical data as input to anticipate new output values. As organizations adopt more advanced security frameworks, the global machine learning market is anticipated to grow as machine learning becomes a prominent trend in security analytics. Due to the massive amount of data being generated and communicated over several networks, cyber professionals struggle considerably to identify and assess potential cyber threats and assaults.

Machine-learning algorithms can assist businesses and security teams in anticipating, detecting, and recognising cyber-attacks more quickly as these risks become more widespread and sophisticated. For example, supply chain attacks increased by 42% in the first quarter of 2021 in the US, affecting up to 7,000,000 people. For instance, AT&T and IBM claim that the promise of edge computing and 5G wireless networking for the digital revolution will be proven. They have created virtual worlds that, when paired with IBM hybrid cloud and AI technologies, allow business clients to truly experience the possibilities of an AT&T connection.

Computer vision is a cutting-edge technique that combines machine learning and deep learning for medical imaging diagnosis. This has been accepted by the Microsoft InnerEye programme, which focuses on image diagnostic tools for image analysis. For instance, using minute samples of linguistic data, an AI model created by a team of researchers from IBM and Pfizer can accurately forecast the eventual onset of Alzheimers disease in healthy persons by 71 percent (obtained via clinical verbal cognition tests).

Read Market Research Report, Global Machine Learning Market by Component, (Solutions, and Services), Enterprise Size (SMEs And Large Enterprises), Deployment (Cloud, On-Premise), End-User [Healthcare, Retail, IT and Telecommunications, Banking, Financial Services and Insurance (BFSI), Automotive & Transportation, Advertising & Media, Manufacturing, Others (Energy & Utilities, Etc.)], and Region Forecast and Analysis 20222028 By Skyquest

Get Sample PDF : https://skyquestt.com/sample-request/machine-learning-market

Large enterprises segment dominated the machine learning market in 2021. This is because data science and artificial intelligence technologies are being used more often to incorporate quantitative insights into business operations. For instance, under a contract between Pitney Bowes and IBM, IBM will offer managed infrastructure, IT automation, and machine learning services to help Pitney Bowes convert and adopt hybrid cloud computing to support its global business strategy and goals.

Small and midsized firms are expected to grow considerably throughout the anticipated timeframe. It is projected that AI and ML would be the main technologies allowing SMEs to reduce ICT investments and access digital resources. For instance, the IPwe Platform, IPwe Registry, and Global Patent Marketplace are just a few of the small- and medium-sized firms (SMEs) and other organizations that are reportedly already using IPwes technology.

The healthcare sector had the biggest share the global machine learning market in 2021 owing to the industrys leading market players doing rapid research and development, as well as the partnerships formed in an effort to increase their market share. For instance, per the terms of the two businesses signed definitive agreement, Francisco Partners would buy IBMs healthcare data and analytics assets that are presently a part of the Watson Health company. An established worldwide investment company with a focus on working with IT startups is called Francisco Partners. Francisco Partners acquired a wide range of assets, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software services.

The prominent market players are constantly adopting various innovation and growth strategies to capture more market share. The key market players are IBM Corporation, SAP SE, Oracle Corporation, Hewlett Packard Enterprise Company, Microsoft Corporation, Amazon Inc., Intel Corporation, Fair Isaac Corporation, SAS Institute Inc., BigML, Inc., among others.

The report published by SkyQuest Technology Consulting provides in-depth qualitative insights, historical data, and verifiable projections about Machine Learning Market Revenue. The projections featured in the report have been derived using proven research methodologies and assumptions.

Speak With Our Analyst : https://skyquestt.com/speak-with-analyst/machine-learning-market

Report Findings

What does this Report Deliver?

SkyQuest has Segmented the Global Machine Learning Market based on Component, Enterprise Size, Deployment, End-User, and Region:

Read Full Report : https://skyquestt.com/report/machine-learning-market

Key Players in the Global Machine Learning Market

About Us-SkyQuest Technology Group is a Global Market Intelligence, Innovation Management & Commercialization organization that connects innovation to new markets, networks & collaborators for achieving Sustainable Development Goals.

Find Insightful Blogs/Case Studies on Our Website:Market Research Case Studies

Go here to see the original:
Global Machine Learning Market is Expected to Grow at a CAGR of 39.2 % by 2028 - Digital Journal

Covision Quality joins NVIDIA Metropolis to scale its industrial visual inspection software leveraging unsupervised machine learning – GlobeNewswire

BRESSANONE, Italy, July 25, 2022 (GLOBE NEWSWIRE) -- Covision Quality, a leading provider of visual inspection software based on unsupervised machine learning technology, today announced it has joined NVIDIA Metropolis a partner program, application framework, and set of developer tools that bring to market a new generation of vision AI applications that make the worlds most important spaces and operations safer and more efficient.

Covision Qualitys interface from the perspective of the end-of-line quality control operator. In this case, the red border on the image of the manufactured part indicates that the part is not OK, thus can not be sent to the end customer and needs to be discarded.

Thanks to its unsupervised machine learning technology, the Covision Quality software can be trained in an hour on average and generates reduction of pseudo-scrap rates by up to 90% for its customers. Its workstations that are deployed at customer sites harness the power of NVIDIA RTX A5000 GPU-accelerated computing, which allows the software to run in real time processing images, inspecting components, and communicating decisions to the PLC. In addition, Covision Quality leverages NVIDIA Metropolis, the TensorRT SDK, and CUDA software.

NVIDIA Metropolis makes it easier and more cost effective for enterprises, governments, and integration partners to use world-class AI-enabled solutions to improve critical operational efficiency and solve safety problems. The NVIDIA Metropolis ecosystem contains a large and growing breadth of members who are investing in the most advanced AI techniques and most efficient deployment platforms, and using an enterprise-class approach to their solutions. Members have the opportunity to gain early access to NVIDIA platform updates to further enhance and accelerate their AI application development efforts. The program also offers the opportunity for members to collaborate with industry-leading experts and other AI-driven organizations.

Covision Quality is a spin-off of Covision Lab, a leading European computer vision and machine learning application center and company builder. Covision Quality licenses its visual inspection software product to manufacturing companies in several industries, ranging from metal manufacturing to packaging. Customers of Covision Quality include GKN Sinter Metals, a global market leader for sinter metal components, and Aluflexpack Group, a leading international manufacturer of flexible packaging.

Franz Tschimben, CEO of Covision Quality, sees an important value-add in joining the NVIDIA Metropolis program: Joining NVIDIA Metropolis marks yet another milestone in our companys young history and in our relationship with NVIDIA, which started with our company joining the NVIDIA Inception program last year. It is a testament to the great work the team is doing in providing a scalable visual inspection software product to our customers, drastically reducing time to deployment of visual inspection systems and pseudo scrap rates. We expect that NVIDIA Metropolis, which sits at the heart of many developments that are happening in the industry today, will give us a boost in our go-to-market efforts and support us in connecting to customers and system integrators.

About Covision QualityCovision Quality licenses its visual inspection software product to manufacturing companies in several industries, ranging from metal manufacturing to packaging. Thanks to its unsupervised machine learning technology, the Covision Quality software can be trained in an hour on average and generates reduction of pseudo-scrap rates for its customers by up to 90%. Covision Quality is the recipient of the Cowen Startup award at Automate Show 2022 in Detroit, United States.

Covision Quality is a spin-off of Covision Lab, a leading European computer vision and machine learning application center and company builder.For more information, visit http://www.covisionquality.com

Contact information:Covision Qualityhttps://www.covisionquality.com/en 39042 Bressanone, Italy+39 333 4421494info@covisionlab.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/19998b6c-83b8-41df-8e60-c5d558e3e408

Read this article:
Covision Quality joins NVIDIA Metropolis to scale its industrial visual inspection software leveraging unsupervised machine learning - GlobeNewswire

Explained: How to tell if artificial intelligence is working the way we want it to – MIT News

About a decade ago, deep-learning models started achieving superhuman results on all sorts of tasks, from beating world-champion board game players to outperforming doctors at diagnosing breast cancer.

These powerful deep-learning models are usually based on artificial neural networks, which were first proposed in the 1940s and have become a popular type of machine learning. A computer learns to process data using layers of interconnected nodes, or neurons, that mimic the human brain.

As the field of machine learning has grown, artificial neural networks have grown along with it.

Deep-learning models are now often composed of millions or billions of interconnected nodes in many layers that are trained to perform detection or classification tasks using vast amounts of data. But because the models are so enormously complex, even the researchers who design them dont fully understand how they work. This makes it hard to know whether they are working correctly.

For instance, maybe a model designed to help physicians diagnose patients correctly predicted that a skin lesion was cancerous, but it did so by focusing on an unrelated mark that happens to frequently occur when there is cancerous tissue in a photo, rather than on the cancerous tissue itself. This is known as a spurious correlation. The model gets the prediction right, but it does so for the wrong reason. In a real clinical setting where the mark does not appear on cancer-positive images, it could result in missed diagnoses.

With so much uncertainty swirling around these so-called black-box models, how can one unravel whats going on inside the box?

This puzzle has led to a new and rapidly growing area of study in which researchers develop and test explanation methods (also called interpretability methods) that seek to shed some light on how black-box machine-learning models make predictions.

What are explanation methods?

At their most basic level, explanation methods are either global or local. A local explanation method focuses on explaining how the model made one specific prediction, while global explanations seek to describe the overall behavior of an entire model. This is often done by developing a separate, simpler (and hopefully understandable) model that mimics the larger, black-box model.

But because deep learning models work in fundamentally complex and nonlinear ways, developing an effective global explanation model is particularly challenging. This has led researchers to turn much of their recent focus onto local explanation methods instead, explains Yilun Zhou, a graduate student in the Interactive Robotics Group of the Computer Science and Artificial Intelligence Laboratory (CSAIL) who studies models, algorithms, and evaluations in interpretable machine learning.

The most popular types of local explanation methods fall into three broad categories.

The first and most widely used type of explanation method is known as feature attribution. Feature attribution methods show which features were most important when the model made a specific decision.

Features are the input variables that are fed to a machine-learning model and used in its prediction. When the data are tabular, features are drawn from the columns in a dataset (they are transformed using a variety of techniques so the model can process the raw data). For image-processing tasks, on the other hand, every pixel in an image is a feature. If a model predicts that an X-ray image shows cancer, for instance, the feature attribution method would highlight the pixels in that specific X-ray that were most important for the models prediction.

Essentially, feature attribution methods show what the model pays the most attention to when it makes a prediction.

Using this feature attribution explanation, you can check to see whether a spurious correlation is a concern. For instance, it will show if the pixels in a watermark are highlighted or if the pixels in an actual tumor are highlighted, says Zhou.

A second type of explanation method is known as a counterfactual explanation. Given an input and a models prediction, these methods show how to change that input so it falls into another class. For instance, if a machine-learning model predicts that a borrower would be denied a loan, the counterfactual explanation shows what factors need to change so her loan application is accepted. Perhaps her credit score or income, both features used in the models prediction, need to be higher for her to be approved.

The good thing about this explanation method is it tells you exactly how you need to change the input to flip the decision, which could have practical usage. For someone who is applying for a mortgage and didnt get it, this explanation would tell them what they need to do to achieve their desired outcome, he says.

The third category of explanation methods are known as sample importance explanations. Unlike the others, this method requires access to the data that were used to train the model.

A sample importance explanation will show which training sample a model relied on most when it made a specific prediction; ideally, this is the most similar sample to the input data. This type of explanation is particularly useful if one observes a seemingly irrational prediction. There may have been a data entry error that affected a particular sample that was used to train the model. With this knowledge, one could fix that sample and retrain the model to improve its accuracy.

How are explanation methods used?

One motivation for developing these explanations is to perform quality assurance and debug the model. With more understanding of how features impact a models decision, for instance, one could identify that a model is working incorrectly and intervene to fix the problem, or toss the model out and start over.

Another, more recent, area of research is exploring the use of machine-learning models to discover scientific patterns that humans havent uncovered before. For instance, a cancer diagnosing model that outperforms clinicians could be faulty, or it could actually be picking up on some hidden patterns in an X-ray image that represent an early pathological pathway for cancer that were either unknown to human doctors or thought to be irrelevant, Zhou says.

It's still very early days for that area of research, however.

Words of warning

While explanation methods can sometimes be useful for machine-learning practitioners when they are trying to catch bugs in their models or understand the inner-workings of a system, end-users should proceed with caution when trying to use them in practice, says Marzyeh Ghassemi, an assistant professor and head of the Healthy ML Group in CSAIL.

As machine learning has been adopted in more disciplines, from health care to education, explanation methods are being used to help decision makers better understand a models predictions so they know when to trust the model and use its guidance in practice. But Ghassemi warns against using these methods in that way.

We have found that explanations make people, both experts and nonexperts, overconfident in the ability or the advice of a specific recommendation system. I think it is very important for humans not to turn off that internal circuitry asking, let me question the advice that I amgiven, she says.

Scientists know explanations make people over-confident based on other recent work, she adds, citing some recent studies by Microsoft researchers.

Far from a silver bullet, explanation methods have their share of problems. For one, Ghassemis recent research has shown that explanation methods can perpetuate biases and lead to worse outcomes for people from disadvantaged groups.

Another pitfall of explanation methods is that it is often impossible to tell if the explanation method is correct in the first place. One would need to compare the explanations to the actual model, but since the user doesnt know how the model works, this is circular logic, Zhou says.

He and other researchers are working on improving explanation methods so they are more faithful to the actual models predictions, but Zhou cautions that, even the best explanation should be taken with a grain of salt.

In addition, people generally perceive these models to be human-like decision makers, and we are prone to overgeneralization. We need to calm people down and hold them back to really make sure that the generalized model understanding they build from these local explanations are balanced, he adds.

Zhous most recent research seeks to do just that.

Whats next for machine-learning explanation methods?

Rather than focusing on providing explanations, Ghassemi argues that more effort needs to be done by the research community to study how information is presented to decision makers so they understand it, and more regulation needs to be put in place to ensure machine-learning models are used responsibly in practice. Better explanation methods alone arent the answer.

I have been excited to see that there is a lot more recognition, even in industry, that we cant just take this information and make a pretty dashboard and assume people will perform better with that. You need to have measurable improvements in action, and Im hoping that leads to real guidelines about improving the way we display information in these deeply technical fields, like medicine, she says.

And in addition to new work focused on improving explanations, Zhou expects to see more research related to explanation methods for specific use cases, such as model debugging, scientific discovery, fairness auditing, and safety assurance. By identifying fine-grained characteristics of explanation methods and the requirements of different use cases, researchers could establish a theory that would match explanations with specific scenarios, which could help overcome some of the pitfalls that come from using them in real-world scenarios.

Link:
Explained: How to tell if artificial intelligence is working the way we want it to - MIT News

Healthcare Nanotechnology (Nanomedicine) Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2029 This Is Ardee – This…

New Jersey, United States TheHealthcare Nanotechnology (Nanomedicine)Market research guides new entrants to obtain precise market data and communicates with customers to know their requirements and preferences. It spots outright business opportunities and helps to bring new products into the market. It identifies opportunities in the marketplace. It aims at doing modifications in the business to make business procedures smooth and make business forward. It helps business players to make sound decision making. Healthcare Nanotechnology (Nanomedicine) market report helps to reduce business risks and provides ways to deal with upcoming challenges. Market information provided here helps new entrants to take informed decisions making. It emphasizes on major regions of the globe such as Europe, North America, Asia Pacific, Middle East, Africa, and Latin America along with their market size.

Such unique Healthcare Nanotechnology (Nanomedicine) Market research report offers some extensive strategic plans that help the players to deal with the current market situation and make your position. It helps in strengthening your business position. It offers better understanding of the market and keep perspective to aid one remain ahead in this competitive market. Organizations can gauze and compare their presentation with others in the market on the basis of this prompt market report. This market report offers a clarified picture of the varying market tactics and thereby helps the business organizations gain bigger profits. You get a clear idea about the product launches, trade regulations and expansion of the market place through this market report.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.verifiedmarketresearch.com/download-sample/?rid=63885

Key Players Mentioned in the Healthcare Nanotechnology (Nanomedicine) Market Research Report:

Sanofi SA, Pfizer Inc., Celgene Corporation, Luminex Corporation, Taiwan Liposome Company Ltd. And others.

Healthcare Nanotechnology (Nanomedicine)Market report consists of important data about the entire market environment of products or services offered by different industry players. It enables industries to know the market scenario of a particular product or service including demand, supply, market structure, pricing structure, and trend analysis. It is of great assistance in the product market development. It further depicts essential data regarding customers, products, competition, and market growth factors. Healthcare Nanotechnology (Nanomedicine) market research benefits greatly to make the proper decision. Future trends are also revealed for particular products or services to help business players in making the right investment and launching products into the market.

Healthcare Nanotechnology (Nanomedicine)Market Segmentation:

Global Healthcare Nanotechnology (Nanomedicine) Market By Disease

Cardiovascular Diseases Oncological Diseases Neurological Diseases Orthopedic Diseases Infectious Diseases Other

Healthcare Nanotechnology (Nanomedicine) Market By Application

Drug Delivery Biomaterials Active Implants Diagnostics Imaging Tissue Regeneration Othes

Inquire for a Discount on this Premium Report@ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=63885

For Prepare TOC Our Analyst deep Researched the Following Things:

Report Overview:It includes major players of the Healthcare Nanotechnology (Nanomedicine) market covered in the research study, research scope, market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the Healthcare Nanotechnology (Nanomedicine) market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the Healthcare Nanotechnology (Nanomedicine) market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the Healthcare Nanotechnology (Nanomedicine) market by application, it gives a study on the consumption in the Healthcare Nanotechnology (Nanomedicine) market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the Healthcare Nanotechnology (Nanomedicine) market are profiled in this section. The analysts have provided information about their recent developments in the Healthcare Nanotechnology (Nanomedicine) market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the Healthcare Nanotechnology (Nanomedicine) market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the Healthcare Nanotechnology (Nanomedicine) market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the Healthcare Nanotechnology (Nanomedicine) market.

Key Findings:This section gives a quick look at the important findings of the research study.

For More Information or Query or Customization Before Buying, Visit @ https://www.verifiedmarketresearch.com/product/healthcare-nanotechnology-nanomedicine-market/

About Us: Verified Market Research

Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. We offer insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecast, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.

We, at Verified Market Research, assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.

Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the worlds leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research

US: +1 (650)-781-4080UK: +44 (753)-715-0008APAC: +61 (488)-85-9400US Toll-Free: +1 (800)-782-1768

Email: sales@verifiedmarketresearch.com

Website:- https://www.verifiedmarketresearch.com/

Read more:
Healthcare Nanotechnology (Nanomedicine) Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2029 This Is Ardee - This...

Fundamental Knowledge on Nanobots – Bio-IT World

Nanorobots are electromechanical devices comprised of components that are within the nanometer size range. Within medicine, nanorobotic applications have been successfully used for a variety of microbiological, hematological, surgical and dental applications, to name a few.

The nanobots market global size accounted for USD 5.3 billion in 2021 and is expected to reach around USD 21.45 billion by 2030, expected to register growth at a CAGR of 16.8% from 2022 to 2030.

What is Biomedical Nanorobots?

As compared to industrial robots that were originally developed to automate routine and dangerous tasks, biomedical robots are highly specialized and miniature devices that must be capable of performing precise tasks within the human body. Recent advancements in nanotechnology and materials science have therefore promoted the development of both micro- and nanorobots for a wide range of biomedical applications.

Whereas the traditional power sources for industrial robots that require large power supplies and/or battery storage capabilities, both micro- and nanorobots will typically depend on chemically powered motors for their energy needs. To this end, these motors acquire energy by converting locally supplied fuels, such as oxygen or glucose within the body, to propel themselves towards different cellular structures. Nanorobots can also rely on externally powered motors based on either magnetic or ultrasound technology to drive their motion.

One of the most challenges that biomedical researchers have faced during the miniaturization of robotic systems has been the optimization of nanolocomotion. Recent developments in this field have demonstrated the ability of both micro- and nanorobots to efficiently propel themselves through complex biological media or narrow blood vessels. Furthermore, once these microscopic robots have penetrated through these areas, researchers have successfully developed ways in which these devices can collect and remove tissue biopsy samples, obtain detailed images, release active agents at predetermined locations and perform localized diagnoses.

Key market players

Report Scope of theNanobots Market

USD 21.45 Billion

Segments covered in the report

By Type

By Application

By Type of Manufacturing

By End User

Regional Segment

Nanomedicine segment is expected to dominate the application segment of the nanobots market

Based on application, the nanobots market is segmented into nanomedicine, biomedical and other applications. The Nanomedicine segment is expected to dominate the global nanobots market by holding more than 36% of the overall market. Nanobots are widely used in nanomedicine due to the increasing healthcare applications of nanobots. The large market share of this segment is attributed to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, active implants, in vitro diagnostic, biomaterial, and drug therapy.

Additionally, increasing innovations in the field of cancer treatment related to the specific target are also contributing to the growth of nanobots market. The biomedical applications segment accounted for the second-largest market share of the overall nanobots marketplace.

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Download a FREE PDF Brochure https://www.precedenceresearch.com/sample/1914

Read the rest here:
Fundamental Knowledge on Nanobots - Bio-IT World

Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma’s Nano-in and No-Pass Mimic Nanoparticle Technologies in Anti-Aging and…

Ponce Therapeutic's ("Ponce") lead product, ReBeaut, is a microneedle patch containing nanoparticles carrying its proprietary ApoptiCIDecell elimination gene therapy technology targeting senescent keratinocytes and fibroblasts in the skin

Speratum Biopharma ("Speratum") will receive an upfront payment, pre-clinical and clinical milestone payments, and a royalty on worldwide net sales of Licensed Products incorporating their technology

Ponce's exclusive license allows it to utilize the licensed technology to extend its gene therapy clinical portfolio to include any skin disorders, benign or malignant and all anti-aging applications, whether delivered locally or systemically

MIAMI, July 25, 2022 /PRNewswire/ -- Ponce Therapeutics, Inc., a company leveraging the growing scientific knowledge surrounding the aging process to develop anti-aging technologies, announced today that it had executed a worldwide, exclusive license to Speratum'sproprietary Nano-inand No-Pass Mimictechnologies to advance its lead product, ReBeaut, a state-of-the-art biotechnology platform to restore the youthful balance of aged or "senescent" and young, vital cells in the skin, targeting the senescent cells for elimination, providing a "reboot" of the skin's composition back to its youthful exuberance. Speratum's Nano-in is a proprietary, biocompatible polymer, LGA-PEI, that can condense with nucleic acids to form nanoparticles for drug delivery that can be used in vivo with a favorable pre-clinical toxicity profile. Nano-inwill be used to deliver Ponce's ApoptiCIDecell elimination technology into the skin via a proprietary dissolvable microneedle delivery platform. Ponce's exclusive license allows it to utilize the licensed technology to extend its gene therapy clinical portfolio to include any disorder of the skin, benign and malignant, including all dermatologic and cosmetic applications, skin-mediated gene therapy and skin-mediated delivery of small peptides, peptide-like molecules and other small molecules, and all anti-aging indications, whether delivered locally or systemically.

Story continues

Ponce Therapeutics, Inc.

PONCE Therapeutics, Inc. (https://poncetherapeutics.com), a biotech company leveraging the growing scientific knowledge surrounding the process of aging to develop products to arrest or reverse the aging process, was founded by Kevin Slawin, MD, Chairman and CEO and David Spencer, PhD., Chief Technology Officer, reuniting the team that founded Bellicum Pharmaceuticals and took it public in 2014 with a $55 million crossover Series C and a $161 million IPO. The team is retooling their original cell control technology with state-of-the-art advances ("ApoptiCIDe") towards their new goal of creating anti-aging products with a solid underlying scientific basis. Ponce Therapeutics began operations in January 2021 and operates in laboratory space in K2 Biolabs (https://k2-biolabs.com) in Houston, TX. Dr. Slawin is a founding Board Member of K2 Bio and both Drs. Slawin and Spencer are investors. Drs. Slawin and Spencer are also joined by Damian Young, Ph.D., CSO, and Kayvon Namvar, CFO, as the founders of DELIVER Therapeutics, Inc. (https://deliverthera.com)a company that plans to applynovel, high-throughput screening technologiescombinedwith chemical innovation to DELIVER therapeutics, including novel anti-aging therapeutics, that address the most difficult problems in clinical medicine and that is also situated at K2 Bio.

Ponce's founding lead investor, Rapha Capital, is an investment management firm focused on making strategic investments in early stage, non-public biotechnology companies, through special purpose, joint venture entities which it manages. Rapha Capital was founded by its President, Kevin Slawin, M.D., a successful and experienced oncologic and robotic surgeon. In addition to founding Bellicum Pharmaceuticals, Inc.("Bellicum"), a publicly traded company listed on NASDAQ, he also plays a guiding role in several of the investments managed by Rapha Capital in certain companies, serving as Board Chairman of Imagin Medical, Inc. (https://imaginmedical.com), a publicly traded company (OTC: IMEXF), and FIZE Medical, Inc. (https://fizemedical.com), and a board member at 3DBio Therapeutics, Inc. (https://3dbiocorp.com/), and Demeetra AgBio, Inc. (http://demeetra.com). Together with Dr. Mitch Steiner, CEO of Veru, Inc., he is the Founder, CEO and Chairman of Miami MediCo.s (https://miamimedicos.com), a network of physicians, founders, executives and investors working to expand the entrepreneurial healthcare ecosystem in Miami.

"The science of aging has continued to mature and can now provide a scientific basis for technologies to reverse the aging process in humans. Proof of concept data in animal models demonstrates that removal of senescent cells from organs improves their function and imbues them with a more youthful profile," said Dr. Slawin. "I'm excited to be taking another important step towards the clinic in the anti-aging space, which I believe will quickly rival oncology in both value and interest" he added. "With this license, we are building the necessary technology platform to deliver our first product, beginning with the skin, allowing us to leverage an increasingly detailed, mechanistic understanding of aging to arrest or even reverse it," added Dr. Spencer.

"We are gratified to begin this collaboration with the team at Ponce that utilizes our novel technologies as part of their therapeutic platform," said Dr. Christian Marin-Mueller, the founder and CEO of Speratum and the inventor of Nano-inand No-Pass Mimic technologies. Dr. Thilo Bayrhoffer, Speratum Biopharma lead investor, treasurer, and member of the board added "Our patented technologies, combining synthetic biology with nanotechnology, are needed to develop modifiable and adaptable therapeutic platforms for targeted nucleic acid delivery. Following a research collaboration with Roche in 2021, this is the first commercial license for our technologies, and it reinforces our commitment to further Speratum' s therapeutic programs, including MiR198 targeting pancreatic cancer, which is expected to be in the clinic by 2024."

About Ponce Therapeutics, Inc.

Ponce Therapeutics "Anti-aging Technologies Based on Real Science and Developed by Real Scientists" Ponce Therapeutics is leveraging the growing scientific knowledge surrounding the process of aging to develop its first state-of-the-art biotechnology platform to restore the youthful balance of aged or "senescent" and young cells in the skin, targeting senescent cells for elimination. This provides a "reboot" of one's genetic program to turn the clock on one's skin back to its youthful exuberance. While initially focused on skin, Ponce is planning to develop a wide-ranging portfolio of anti-aging products based on the best science in the nascent anti-aging field. Ponce is headquartered in Miami, Florida with research facilities located in Houston, TX.

For more information about PONCE Therapeutics, email info@poncethera.comor visit https://poncetherapeutics.com

About Speratum Biopharma, Inc.

Speratum Biopharma, Inc. ("Speratum") is an innovative biotechnology company focused on research and development of targeted oligonucleotide delivery systems and nucleic acid therapeutics, including No-Pass MimicmicroRNA ("miRNA) for the treatment of cancer. The company was founded in 2014 with technologies licensed from Baylor College of Medicine ("Baylor"). Since then, Speratum has combined these with best-in class, proprietary nanotechnologies to generate a ground-breaking oligonucleotide and cell therapy platform. Speratum is currently in final pre-clinical stages of development for its first therapeutic, a small RNA tumor suppressor against pancreatic, ovarian, and other cancers that includes a proprietary RNA interference ("RNAi")-inducing mimic of miR-198, a naturally occurring microRNA involved in the pathogenesis of a number of solid cancers. Speratum's Nano-inand No-Pass Mimictechnologies are also being studied in other oligonucleotide research areas and therapeutic modalities such as circular RNA ("circRNAs").

For more information about Speratum Biopharma, please visit https://speratum.comor e-mail info@speratum.com

About Rapha Capital Management, LLC and Rapha Capital BioVentures Fund I, LP Rapha Capital Management, LLC is an investment management firm located in Miami, Florida, focusing on strategic investments in early stage, non-public biotechnology companies. Rapha Capital was founded by its President, Kevin Slawin, MD, a successful and experienced oncologic and robotic surgeon, biotech consultant, investor, and founder focusing on technologies in oncology, T cells and immunotherapy, as well as other breakthrough healthcare technologies. Rapha Capital Management manages thirteen legacy SPIVs, Rapha Capital Investment I XIII. Rapha Capital Management offers alternative asset management services to the RCBV Fund, which has more recently been the vehicle for both new and follow-on investments managed by Rapha Capital Management.

For more information about Rapha Capital Management, email info@raphacapital.comor visit https://www.raphacap.com

(PRNewsfoto/Rapha Capital Management, LLC)

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ponce-therapeutics-executes-worldwide-exclusive-license-to-speratum-biopharmas-nano-in-and-no-pass-mimic-nanoparticle-technologies-in-anti-aging-and-other-products-initially-for-skin-301591809.html

SOURCE Ponce Therapeutics, Inc.

Originally posted here:
Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in and No-Pass Mimic Nanoparticle Technologies in Anti-Aging and...

What is medtech and where will it go next? – Verdict

Medtech startups are going from strength to strength. Investors have upped the funding dosage injected into the industry every year over the past decade.

However, that doesnt explain what medtech is or why venture capitalists are so eagerly betting on the sectors future.

But dont worry, weve got you covered.

Medtech stands for medicinal or medical technology. It is shorthand for technologies used within the medical realm.

Now, technically one could argue that things like scalpels, X-rays and stethoscopes would also fall under this category. After all, they were high-tech when they first popped into the scene and they are, undoubtedly, used by doctors around the planet.

However, the term medtech mainly applies to modern technologies with novel applications in healthcare. In other words: the term refers to high-tech solutions like artificial intelligence (AI) systems and robotics being used by doctors, nurses, pharmacologists and other medical practitioners.

And this prospect has clearly caught the imagination of investors

VCs have backed medtech en masse over the past decade. In 2013, investors injected $914m into the global industry across 220 deals, according to data from research firm GlobalData. The number of deals have climbed year on year since. In 2021, VCs bet $38.2bn on the industry across 1,161 deals.

However, there are signs that the flow of investment could be slowing down. As of July 25, only $11.7bn have been injected into the industry across 506 deals. This could be due to industry being caught up in the same macro economic whirlwinds the war in Ukraine, the end of the pandemic, rising inflation, new regulation to mention a few factors that now threatens to pop the tech bubble.

Time will tell whether investment will cool down like it seems to do for the tech industry in general.

Medtech has several applications. The first one worth mentioning is telemedicine. In a push to marry health with convenience, tech companies are developing ways that we can look after ourselves from home. Telemedicine became commonplace during the pandemic, and it has persevered; even now many continue to speak to their GPs over the phone. Following the pandemic, telemedicine services have been repurposed as one of the ways technology can help cities beat the next heatwave.

Beyond the pandemic, handheld and wearable remote patient monitoring devices transmit healthcare data to doctors and further innovations place the power to thrive directly into patients' pockets. For example, wearable blood-glucose monitors remind diabetic patients to take their insulin and specialist mobile games help children with ADHD sustain concentration for longer.

Medtech innovators are also increasingly tapping into the Internet of Things, (IoT), a system of wireless, interrelated and connected digital devices. By connecting medical devices to a server, doctors can, for instance, monitor patients' health remotely.

GlobalData estimates that the global market for IoT platforms for healthcare providers will jump from $10.6bn in 2020 to reach $13.3bn in 2025.

Medtech can also help patients in hospitals in a number of ways.

For instance, tricorders are handheld computers that use sensors, like cameras, to detect a range of health conditions. These time-saving devices, once merely a science-fiction, can now diagnose with at least the accuracy of a physician.

The list of new technologies that will permeate healthcare includes augmented reality (AR). AR headsets will allow surgeons to cycle through different scans of a patient during an operation. Other AR headsets will help to train medical students.

Robotics are already providing help during surgery. Doctors in Seattle already allow robotic appendages to lend a steady hand during minimally-invasive procedures on the brain.

AI has a plethora of applications in healthcare. To mention a few, AI can identify abnormalities on scans that might otherwise go overlooked. AI might also speed up clinical trials. Systems that simulate how a chemical will interact in the body are currently under development.

Interestingly, another AI has even formulated a potential medicine. Supercomputers during Covid-19 also helped to develop the vaccine that enabled us to get back to the new normal, whatever that is. Supercomputers are clusters of interconnected computers with an accumulated processing power that put todays fastest home desktops to shame.

AI have also been combined with robotics in order to improve the length and quality of life of patients suffering from motor neurone disease.

Fascinating developments in nanotechnology continue to broaden the horizons of medicine. Notably, nanomedicine can ensure that chemicals only reach targeted locations in the body. Radioactive medicines are encased in a nanostructure to protect organs, and when the medicine reaches the target location ultrasound is used to break open the casing.

The applications of technology in healthcare are vast and open ended. We have just scratched the surface of the wealth of possibilities in 21st Century medtech.

So it's unsurprising that another few CCs of VC funding for the medtech sector is just what the doctor ordered.

Excerpt from:
What is medtech and where will it go next? - Verdict

Aviceda Therapeutics Announces Key Opinion Leader in Ophthalmology Drug Development Tarek S. Hassan, MD to Join Management Team as Chief Development…

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics, Inc. a private biotechnology company located in Cambridge MA with a proprietary nano-technology HALOS platform (High-Affinity Ligands Of Siglecs), announced today the appointment of Tarek S. Hassan, MD, FASRS as Chief Development Officer and Senior Vice-President. He joins other leaders in the fields of retina and immunologic-based science and therapeutics, Drs. Mohamed Genead, David Callanan, Michael Tolentino, Derek Kunimoto, and Christopher Scott, as part of the executive management team.

Aviceda Therapeutics is an innovative clinical stage biotechnology company focused on developing transformative glyco-therapeutic drugs that modulate dysregulated inflammation in a diverse range of diseases that affect large unserved and underserved populations. Avicedas short-term focus is the initiation of the clinical trial for its lead product, AVD-104, a Ph II ready ophthalmic lead product for geographic atrophy (GA) secondary to dry AMD (dAMD). Dr. Hassan is ideally suited to manage the development of AVD-104 and move the company forward to bring its breakthrough therapies to the clinic, address significant unmet medical needs, and ultimately transform lives.

Aviceda is honored to have one of the most renowned and successful leaders in retina and strategic drug development join the Aviceda team in this key position. We believe that we have assembled the top team in ophthalmology and beyond. With our lead product about to enter clinical trials for GA associated with dry AMD, this is an ideal time for Tarek to join our management team. Given the broad potential of our HALOS technology pipeline, todays announcement marks a major step forward in advancing Aviceda as leading company in the field of retina and beyond, said Dr. Genead, co-founder and CEO of Aviceda Therapeutics.

I am honored to join the outstanding team of thought leaders in the fields of retina, glycobiology, and immune therapy at Aviceda, said Dr. Tarek Hassan. I am excited to complete the planning and oversee the execution of the Phase 2 trial for AVD-104 for GA associated with AMD. This critical indication affects a large patient population and has no current treatment. We have an outstanding opportunity to make major contributions towards finding a treatment for patients with this serious blinding disease, particularly through our innovative approach of developing immune modulators that act on the switches that turn pathologic mechanisms on and off. We see glyco-immune modulation as a powerful next generation mechanism for the treatment of many acute and chronic diseases of degeneration and inflammation, as well as diseases resulting from immune evasion.

About Tarek Hassan

Tarek S. Hassan, MD is Professor of Ophthalmology at Oakland University William Beaumont School of Medicine, Director of the Vitreoretinal Fellowship Training Program and Senior Partner at Associated Retinal Consultants in Royal Oak, Michigan. He is the current President of the Retina Hall of Fame, Immediate Past President of the Retina World Congress (RWC), Past President of the American Society of Retina Specialists (ASRS), and Past President of the Foundation of the ASRS. He has been on the Executive Board of Directors of the RWC for the past 6 years. He served on the Executive Committee of the ASRS and the Foundation of the ASRS for 12 years and on the Board of Directors of the ASRS for 22 years. He is a Founder and Director of the Retina Fellows Forum (22 years), Club Vit (24 years), and Retina Hall of Fame (6 years).

Dr. Hassan has an active academic clinical practice in which he is extensively involved in a wide variety of clinical vitreoretinal research studies. He has been principal investigator or co-investigator in more than 150 randomized clinical trials, authored and co-authored more than 230 papers in peer-reviewed journals, and written 9 books and/or book chapters for medical texts. He is Senior Associate Editor of the Journal of Vitreoretinal Diseases, as well as an editorial board member and scientific reviewer for other leading journals within ophthalmology and retina. He has given over 760 national and international presentations on many retinal topics and been awarded the American Academy of Ophthalmology (AAO) Achievement Award, the ASRS Senior Honor Award, and the AAO Senior Achievement Award. He was elected as an inaugural member of the Retina Hall of Fame in 2017. He founded, or co-founded several medical device and educational companies, and been granted numerous government-issued device patents.

Born in Houston, Texas, Dr. Hassan obtained his undergraduate, medical school, and residency training at the University of Michigan in Ann Arbor, Michigan and then completed a vitreoretinal diseases and surgery fellowship at Associated Retinal Consultants in Royal Oak.

About Aviceda Therapeutics Inc.

Aviceda is a private biotechnology company located in Cambridge MA with a proprietary nano-technology HALOS platform and an IND-ready ophthalmic lead product for (GA) secondary to dAMD.

Avicedas lead product, AVD-104, is an intravitreal nanoparticle using HALOS technology with a dual mechanism of action (MOA) for GA/dAMD on critical complement and inflammatory pathways.

Read the rest here:
Aviceda Therapeutics Announces Key Opinion Leader in Ophthalmology Drug Development Tarek S. Hassan, MD to Join Management Team as Chief Development...

Biologys hardest working pigments and MOFs – EurekAlert

image:Illustration of the wide range of electrocatalytic and photocatalytic processes and applications for porphyrin framework materials view more

Credit: Nano Research Energy, Tsinghua University Press

Some of the economic sectors that are the hardest to decarbonize would benefit from the emergence of substantially more efficient catalysts involved in energy conversion chemical reactions. A breakthrough here might depend upon the use of pigments widely deployed in biological processes integrated as a catalyst into novel and highly porous molecular structures that act sort of like sponges.

A paper describing the state of play in this field and the challenges it faces was published in the journal Nano Research Energyon May 29.

In recent years, porphyrins and metalloporphyrins have played an increasingly important role in biomimetic chemistry, solar energy utilization, medicine, and a great many other applications. But use of porphyrins in electrocatalysis and photocatalysis reactions central to many energy conversion processes useful for the clean transition was found to be unstable, deactivate, and difficult to recycle, which has limited the further development of these energy conversion technologies.

So scientists have begun to consider the integration of porphyrins as the organic ligands (the ion that binds to a central metal atom in a complex molecule) into synthetic molecular structures known as metal-organic frameworks (MOFs) and their twin, covalent-organic frameworks (COFs)known as porphyrin-based framework materials.

This should in principle deliver excellent electrocatalysis and photocatalysis performance as the MOF and COF structures are simple to synthesize and highly designed, thus much more controllable and structurally stable, said Yusuke Yamauchi, a co-author of the paper and researcher with the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland.

The researchers, who are themselves involved in porphyrin-based framework materials development, put together a review article describing the state of play in their field. Such review papers are necessary for young fields to advance as they clarify current understanding, discuss advances and challenges, identify research gaps and can even offer guidelines for policy and tips on best practice, Huan Pang, a co-author of the paper and the researcher with the School of Chemistry and Chemical Engineering at the Yangzhou University, China

The paper explores all the current and potential applications of porphyrin-based framework material catalysts, and finds that there remains great potential, but the field confronts several challenges.

In an economy of net-zero greenhouse gas emissions, not everything can be electrifiedparticularly long-haul heavy transportand so some form of clean fuels, such as carbon-neutral synthetic hydrocarbons, ammonia or hydrogen will be necessary. All these fuels involve the conversion of clean energywhether from the sun, wind, water or uraniuminto transportable and stable chemical energy. Part of this process requires the production of clean hydrogen through the use of electricity, light or heat to split water into its constituent elements, hydrogen and oxygen.

Hydrocarbons are composed of differing ratios of carbon and hydrogen, hence the name. Thus the clean, synthetic versions replacing their dirty fossil cousins will require drawing down carbon dioxide from the atmosphere and transforming it into various usable forms of carbon as an input to be married to the clean hydrogen. To draw down atmospheric carbon and make use of it is also known as carbon capture and utilization (CCU).

All these processes, and many others involved in the clean transition (the move from fossil fuels to clean technologies) such as the use of fuel cells and light collection, are in effect chemical reactions that convert energy from one form to another, more usable form. These chemical reactions require addition of substances known as catalysts that speed the reaction up. Some of those catalysts are extremely expensive such as platinum, or are not efficient enough for the end product to compete with fossil fuels, or produce their own environmental challenges.

Thus the hunt is on for more efficient, cheaper and cleaner catalysts such as porphyrin,

The development of efficient non-precious porphyrin-based framework material catalysts to replace precious metal catalysts remains a significant hurdle. The design and construction of porphyrin blocks currently mainly relies on a highly symmetrical design, which limits the diversity of porphyrin framework families and affects their potential catalytic applications. Novel structures that employ porphyrin units with asymmetric design should be considered to extend the substances utility.

The cost of preparing porphyrin framework materials remains high and so it is urgent that engineers develop new synthesis methods if these catalysts are to be taken up in large-scale industrial applications. Reducing the number of steps required in synthesis is an important research, but it is also extremely difficult to do this.

They conclude however that should such challenges be overcome, porphyrin-based framework materials could be a game-changer in the commercialisation of energy conversion processes essential for some of the sectors that are the very hardest to decarbonize.

Porphyrins are some of biologys hardest working substances. This class of pigments is deployed in a wide array of vital processes, from photosynthesis to breathing. Derivatives of these water-soluble, ring-shaped molecules that bind metal ions include chlorophylls in plants and the hemoglobins that carry oxygen in the blood of animals. They also enhance the catalytic activities of enzymes in a range of other life-giving chemical reactions. Metalloporphyrins are of particular interest with respect to the clean transition due to their role as catalysts in water splitting to produce hydrogen and oxygen.

##

About Nano Research Energy

Nano Research Energy is launched by Tsinghua University Press, aiming at being an international, open-access and interdisciplinary journal. We will publish research on cutting-edge advanced nanomaterials and nanotechnology for energy. It is dedicated to exploring various aspects of energy-related research that utilizes nanomaterials and nanotechnology, including but not limited to energy generation, conversion, storage, conservation, clean energy, etc. Nano Research Energy will publish four types of manuscripts, that is, Communications, Research Articles, Reviews, and Perspectives in an open-access form.

About SciOpen

SciOpen is a professional open access resource for discovery of scientific and technical content published by the Tsinghua University Press and its publishing partners, providing the scholarly publishing community with innovative technology and market-leading capabilities. SciOpen provides end-to-end services across manuscript submission, peer review, content hosting, analytics, and identity management and expert advice to ensure each journals development by offering a range of options across all functions as Journal Layout, Production Services, Editorial Services, Marketing and Promotions, Online Functionality, etc. By digitalizing the publishing process, SciOpen widens the reach, deepens the impact, and accelerates the exchange of ideas.

Nano Research Energy

Porphyrin-based framework materials for energy conversion

29-May-2022

Read the original post:
Biologys hardest working pigments and MOFs - EurekAlert

Nano Therapy Market 2022 Growth Is Expected To See Development Trends and Challenges to 2030 This Is Ardee – This Is Ardee

New York, United States Report Ocean published the latest research report on the Nano Therapy market. In order to comprehend a market holistically, a variety of factors must be evaluated, including demographics, business cycles, and microeconomic requirements that pertain precisely to the market under study. In addition, the Nano Therapy market study demonstrates a detailed examination of the business state, which represents creative ways for company growth, financial factors such as production value, key regions, and growth rate.

Key Companies Covered in theNano TherapyResearch areNanosphere Inc., Cristal Therapeutics, DIM, NanoMedia Solutions Inc., Luna, Nanobiotix, Sirnaomics Inc., Selecta Biosciences Inc., NanoBioMagnetics.n.nu, Nanospectra Biosciences Inc., Tarveda Therapeutics, Parvus Therapeutics, CytImmune Science Inc., Nanoprobes Inc., NanoBio Corporation, Smith and Nephewand other key market players.

TheNano Therapymarket revenue was $$ Million USD in 2016, grew to $$ Million USD in 2022, and will reach $$ Million USD in 2030, with a CAGR of % during 2022-2030.

The Centers for Medicare and Medicaid Services data estimates that the U.S. national healthcare expenditure surpassed US$ 4.1 trillion in 2020 and is forecast to reach US$ 6.2 trillion by 2028. According to the Commonwealth Fund, the U.S. expended nearly 17% of gross domestic product (GDP) on healthcare in 2018. Switzerland was the second-highest-ranking country, expending 12.2%. In addition, New Zealand and Australia devote only 9.3%.Request To Free Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=mai284010

According to the U.S. Bureau of Labor Statistics, employment in healthcare fields is forecast to grow 16% from 2020 to 2030, much quicker than the standard for all occupations, counting about 2.6 million new jobs. This estimated growth is mainly due to an elder population, showing to greater demand for healthcare services. The median annual wage for healthcare practitioners and technical fields (such as registered nurses,0020physicians and surgeons, and dental hygienists) was US$ 75,040 in May 2021, which was greater than the median annual wage for all occupations in the economy of US$ 45,760.

Market Overview

Nano therapy is a branch of nanomedicine that involves using nanoparticles to deliver a drug to a given target location in the body so as to treat the disease through a process known as targeting.

GlobalNano TherapyMarket Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Nano Therapy industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis, opportunities and forecasts. The biggest highlight of the report is to provide companies in the industry with a strategic analysis of the impact of COVID-19. At the same time, this report analyzed the market of leading 20 countries and introduce the market potential of these countries.

Most important types of Nano Therapy products covered in this report are:Nanomaterial and Biological DeviceNano Electronic BiosensorMolecular NanotechnologyImplantable Cardioverter-Defibrillators

Most widely used downstream fields of Nano Therapy market covered in this report are:Cardiovascular DiseaseCancer TherapyDiabetes TreatmentRheumatoid ArthritisOthers

Top countries data covered in this report:United StatesCanadaGermanyUKFranceItalySpainRussiaChinaJapanSouth KoreaAustraliaThailandBrazilArgentinaChileSouth AfricaEgyptUAESaudi Arabia

SPECIAL OFFER (Avail an Up-to 30% discount on this report) :-https://reportocean.com/industry-verticals/sample-request?report_id=mai284010

Chapter 1 is the basis of the entire report. In this chapter, we define the market concept and market scope of Nano Therapy, including product classification, application areas, and the entire report covered area.

Chapter 2 is the core idea of the whole report. In this chapter, we provide a detailed introduction to our research methods and data sources.

Chapter 3 focuses on analyzing the current competitive situation in the Nano Therapy market and provides basic information, market data, product introductions, etc. of leading companies in the industry. At the same time, Chapter 3 includes the highlighted analysisStrategies for Company to Deal with the Impact of COVID-19.

Chapter 4 provides breakdown data of different types of products, as well as market forecasts.

Different application fields have different usage and development prospects of products. Therefore, Chapter 5 provides subdivision data of different application fields and market forecasts.

Chapter 6 includes detailed data of major regions of the world, including detailed data of major regions of the world. North America, Asia Pacific, Europe, South America, Middle East and Africa.

Chapters 7-26 focus on the regional market. We have selected the most representative 20 countries from 197 countries in the world and conducted a detailed analysis and overview of the market development of these countries.

Chapter 27 focuses on market qualitative analysis, providing market driving factor analysis, market development constraints, PEST analysis, industry trends under COVID-19, market entry strategy analysis, etc.

Access full Report Description, TOC, Table of Figure, Chart, etc. @:-https://reportocean.com/industry-verticals/sample-request?report_id=mai284010

Key Points:Define, describe and forecast Nano Therapy product market by type, application, end user and region.Provide enterprise external environment analysis and PEST analysis.Provide strategies for company to deal with the impact of COVID-19.Provide market dynamic analysis, including market driving factors, market development constraints.Provide market entry strategy analysis for new players or players who are ready to enter the market, including market segment definition, client analysis, distribution model, product messaging and positioning, and price strategy analysis.Keep up with international market trends and provide analysis of the impact of the COVID-19 epidemic on major regions of the world.Analyze the market opportunities of stakeholders and provide market leaders with details of the competitive landscape.

Table of Content:

For More Information or Query or Customization Before Buying, Visit @:https://reportocean.com/industry-verticals/sample-request?report_id=mai284010

Key Benefits for Industry Participants & Stakeholders

Key Questions Answered in the Market Report

Request Full Report :-https://reportocean.com/industry-verticals/sample-request?report_id=mai284010

About Report Ocean:We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:Report Ocean:Email:sales@reportocean.comAddress: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 UNITED STATESTel:+1 888 212 3539 (US TOLL FREE)Website:https://www.reportocean.com

Excerpt from:
Nano Therapy Market 2022 Growth Is Expected To See Development Trends and Challenges to 2030 This Is Ardee - This Is Ardee